. Author manuscript; available in PMC: 2019 Nov 22.

Published in final edited form as: Mod Pathol. 2019 Apr 25;32(10):1544–1550. doi: 10.1038/s41379-019-0276-y

Table 2.

Distribution of mutations of UroSEEK gene panel in invasive bladder cancer

	PT1 TUMORS		Muscle-invasive bladder cancer		p-value
UroSEEK genes	101/111	(91%)	40/43	(93%)	0.933
TERTSeqS	80/111	(72%)	27/43	(63%)	0.354
UroSeqS	62/111	(56%)	32/43	(74%)	0.053
FGFR3	21/111	(19%)	5/43	(12%)	0.399
TP53	31/111	(28%)	23/43	(54%)	0.005
PIK3CA	10/111	(9%)	1/43	(2%)	0.273
CDKN2A	5/111	(5%)	7/43	(16%)	0.035
HRAS	3/111	(3%)	1/43	(2%)	1.0
KRAS	3/111	(3%)	0/43	(0%)	0.661
ERBB2	3/111	(3%)	1/43	(2%)	1.0
VHL	4/111	(4%)	0/43	(0%)	0.486
MLL	0/111	(0%)	0/43	(0%)	.
MET	0/111	(0%)	0/43	(0%)	.